Detall de la convocatòria
Característiques
Característica |
---|
Objectiu de la convocatòria
The awards aim to fund cutting-edge research projects that focus on understanding the underlying mechanism of disease, addressing lupus heterogeneity, and identifying novel biomarkers. |
Característiques principals
Examples of pertinent topics include, but are not limited to: |
Lloc de presentació
El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a: Servei de Recerca. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.05.76. Marta López: mlopez4@imim.es Ext.: 1576 Carol Barnwell: cbarnwell@imim.es Ext.: 1670 |
Convocatòria (URL)
Call: https://www.lupusresearch.org/research-and-clinical-trials/research/funding-opportunities/ |
Informació addicional
A two-stage application process will be employed. A 2-page Letter of Intent (LOI) will be used to judge the significance, novelty, and alignment of the proposed project concept with the LRA-Celgene Accelerator Award. LOIs must be submitted electronically via proposalCENTRAL.com by 11:59 pm ET on October 25, 2019. Only applicants whose LOIs have successfully passed this first review stage will be invited to submit full applications. https://proposalcentral.altum.com Instructions and application forms should be downloaded from the proposal CENTRAL. |
Requisits
Individuals with a doctoral degree (MD, PhD, DO, or equivalent), holding a faculty, or equivalent, position and leading an independent research team at an academic, nonprofit, or government research institution are eligible to apply. The Lupus Research Alliance does not impose geographic restriction on its applicants, and researchers working outside of the United States are encouraged to apply. |
Dotació
Up to $150,000 per year (for a maximum of two years - total amount up to $300,000). |
Durada
Maximum 2 years. |
Arxius
Arxiu |
---|
LRA-Celgene-RFA-2019_Final.pdf |